Through the application of the Wave analysis (Hurst, Gann, Swing trading etc) investors can be aware what to expect over the short and mid term. From 16.11 be aware that a retracement might happened. Intensity has to be monitored to understand the type of wave in development (Ti, T+2i or T+3i).
NVO seemingly cannot be stopped and continues the uptrend, I tried to show this in a variety of wars. I added a local demand for another supportive region. The teal support is from september 2022, we are either going to dip into demand and consolidate nearby or jump to 106 in the coming week or two.
NVO is consolidating above the dashed green line which is good news for the bulls. New all time highs are on the horizon. Many have a hard time buying into 52 week highs, but the best compounders spend a lot of their time in this range, that is the nature of successful stocks and companies. I added a local demand that is the green box as a supportive region.
NVO looks like it may breakdown here if this dotted red line of support is broken. RSI is very low but can certainly be lower. Tech stocks are rebounding which may put NVO and others out of favor for a few weeks.
NVO carries my best trade of the year on the last bull-flag setup. This stock appears to be unstoppable even at over a 400 billion dollar market cap.
Pharmaceutical company Novo Nordisk completed its research into the treatment of kidney disease a year ahead of schedule. However, the results will only be published in early 2024. If the company demonstrates convincing positive results, Novo Nordisk's revenue growth prospects will be strong. Today, our focus is on the Novo Nordisk (NYSE: NVO) stock chart. On...
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products,...
hi Traders We can see that NVO is in a bullish trend. It has been forming a rising wedge pattern . We expect the price to break down from the pattern. Our estimated target is 180.46 . Take short position at the breakout point if we get a volume increase.
NVO has had a rather slow break of a bull flag and resumes on an upward channel/ascending triangle, above the top green line and we should see 200$+ in the coming days
RSI over 70. I think it's time for a retracement - possible -15%.
NVO bull flag playing out, weight loss drug hype carrying the stock along with denmark GDP assistance. NVO is larger than the entire GDP of denmark and is assisting in keeping the country from default.
NVO has been killing it lately despite a miss on earnings. Guidance is key here for a positive breakout. If this flag breaks upward we will see 210-220$.
Analyzing the options chain and the chart patterns of NVO Novo Nordisk prior to the earnings report this week, I would consider purchasing the $162.5 strike price Calls with an expiration date of 2023-8-18, for a premium of approximately $6.85. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking...
The PEAD projected a bullish outlook for NYSE:NVO after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 81.82%.
Im looking for mean reversion opportunities in this stock currently. My SL is bassed on time to profit ratio. i dont use stop losses but will get out if theres a 50% decline. I tested for probalistic monthly sharpe ratio outperformance of the s and p 500. I tested for monthly normality with the kolmogrov smirnov statistic. and looked for a non-significant...
My post is primarily a technical analysis. It is important you understand a technical analysis is a forecast and has a probability, and not a statement that it will be absolutely certain. Fundamental analysts (25) have on Trading View a price target of 1020. There is a wide spread, but most are positive about the stock. Novo is still in an ascending trend as...
Gold comparison to Novo Nordisk 90s. Why stocks generally are better than assets.
Testing charting with both sound and video. We need to get a haircut :)